All Stories

  1. Female Sexual Dysfunction: A Problem Hidden in the Shadows

    Article • Current Pharmaceutical Design, October 2021, Bentham Science Publishers

    Konstantinos Imprialos, Konstantinos Koutsampasopoulos

  2. Prevalence, diagnosis and treatment with 3 different statins of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis in military personnel. Do genetics play a role?

    Article • Current Vascular Pharmacology, October 2020, Bentham Science Publishers

    Konstantinos Imprialos, Professor Vasilios Gabriel Athyros, GEORGIOS SFIKAS

  3. Liraglutide as Adjunct to Insulin Treatment in Patients with Type 1 Diabetes: A Systematic Review and Meta-analysis

    Article • Current Diabetes Reviews, April 2020, Bentham Science Publishers

    Prof Vasilios Kotsis, Konstantinos Stavropoulos, Konstantinos Imprialos

  4. Dysmetabolic Iron Overload in Metabolic Syndrome

    Article • Current Pharmaceutical Design, April 2020, Bentham Science Publishers

    Konstantinos Imprialos, Professor Vasilios Gabriel Athyros, Konstantinos Stavropoulos

  5. Primary Aldosteronism: Novel Insights

    Article • Current Hypertension Reviews, February 2020, Bentham Science Publishers

    Konstantinos Stavropoulos, Konstantinos Imprialos

  6. Hypertension in Metabolic Syndrome: Novel Insights

    Article • Current Hypertension Reviews, February 2020, Bentham Science Publishers

    Konstantinos Imprialos, Konstantinos Stavropoulos, Professor Vasilios Gabriel Athyros

  7. The Role of Mineralocorticoid Receptor Antagonists in Heart Failure with Reduced Ejection Fraction

    Article • Current Pharmaceutical Design, April 2019, Bentham Science Publishers

    Konstantinos Imprialos, Konstantinos Stavropoulos

  8. Mineralocorticoid Receptor Antagonists in Essential and Resistant Hypertension

    Article • Current Pharmaceutical Design, April 2019, Bentham Science Publishers

    Konstantinos Imprialos

  9. Understanding the cardiovascular risk with non-insulin antidiabetic drugs

    Article • Expert Opinion on Drug Safety, March 2019, Taylor & Francis

    Konstantinos Imprialos, Professor Vasilios Gabriel Athyros, Konstantinos Stavropoulos

  10. The Role of Statins in the Management of Nonalcoholic Fatty Liver Disease

    Article • Current Pharmaceutical Design, February 2019, Bentham Science Publishers

    Konstantinos Imprialos, Konstantinos Stavropoulos, Professor Vasilios Gabriel Athyros

  11. SGLT-2 Inhibitors in Type 1 Diabetes Mellitus: A Comprehensive Review of the Literature

    Article • Current Clinical Pharmacology, January 2019, Bentham Science Publishers

    Konstantinos Imprialos, Konstantinos Stavropoulos, Professor Vasilios Gabriel Athyros

  12. Combination of SGLT-2 Inhibitors and GLP-1 Receptor Agonists: Potential Benefits in Surrogate and Hard Endpoints

    Article • Current Pharmaceutical Design, September 2018, Bentham Science Publishers

    Konstantinos Imprialos, Konstantinos Stavropoulos, Professor Vasilios Gabriel Athyros

  13. Sodium-glucose Cotransporter 2 Inhibitors: Glucose Lowering Against other Hypoglycemic Agents

    Article • Cardiovascular & Haematological Disorders - Drug Targets, June 2018, Bentham Science Publishers

    Konstantinos Imprialos, Konstantinos Stavropoulos

  14. Sodium-glucose Cotransporter 2 Inhibitors: Nephroprotective Impact on Diabetic Kidney Disease

    Article • Cardiovascular & Haematological Disorders - Drug Targets, June 2018, Bentham Science Publishers

    Konstantinos Imprialos, Konstantinos Stavropoulos, Kyriakos Dimitriadis

  15. Sodium-glucose Cotransporter 2 Inhibitors: Impact on Body Weight and Blood Pressure Compared with other Antidiabetic Drugs

    Article • Cardiovascular & Haematological Disorders - Drug Targets, June 2018, Bentham Science Publishers

    Konstantinos Imprialos, Konstantinos Stavropoulos, Kyriakos Dimitriadis

  16. Pseudohyperaldosteronism due to mumijo consumption during pregnancy: a licorice-like syndrome

    Article • Gynecological Endocrinology, June 2018, Taylor & Francis

    Konstantinos Stavropoulos, Konstantinos Imprialos

  17. Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk

    Article • Current Vascular Pharmacology, March 2018, Bentham Science Publishers

    Konstantinos Imprialos, Professor Vasilios Gabriel Athyros

  18. Subclinical target organ damage in primary aldosteronism

    Article • Journal of Hypertension, March 2018, Wolters Kluwer Health

    Konstantinos Imprialos

  19. What is the role of statins in the elderly population?

    Article • Expert Review of Clinical Pharmacology, February 2018, Taylor & Francis

    Konstantinos Imprialos, Konstantinos Stavropoulos, Professor Vasilios Gabriel Athyros

  20. Renal resistive index for renovascular hypertension: In the quest of the Holy Grail

    Article • Journal of Clinical Hypertension, February 2018, Wiley

    Konstantinos Imprialos, Konstantinos Stavropoulos

  21. The potential role of statins in treating liver disease

    Article • Expert Review of Gastroenterology & Hepatology, February 2018, Taylor & Francis

    Konstantinos Imprialos, Konstantinos Stavropoulos, Professor Vasilios Gabriel Athyros

  22. Carotid intima-media thickness as a target-organ damage and treatment-target: Need for a major revision?

    Article • Journal of Clinical Hypertension, February 2018, Wiley

    Konstantinos Imprialos, Konstantinos Stavropoulos, Professor Vasilios Gabriel Athyros

  23. Sexual Dysfunction, Cardiovascular Risk and Effects of Pharmacotherapy

    Article • Current Vascular Pharmacology, January 2018, Bentham Science Publishers

    Konstantinos Imprialos, Konstantinos Stavropoulos

  24. Peripheral arterial stiffness as a surrogate of central hemodynamics: A new era for cardiovascular risk estimation?

    Article • Journal of Clinical Hypertension, January 2018, Wiley

    Konstantinos Imprialos

  25. Sacubitril/valsartan instead of renin-angiotensin system inhibition alone: A step forward in resistant hypertension

    Article • Journal of Clinical Hypertension, December 2017, Wiley

    Konstantinos Stavropoulos, Konstantinos Imprialos

  26. Antihypertensive drug treatment: the real-life challenge

    Article • Journal of Clinical Hypertension, December 2017, Wiley

    Konstantinos Stavropoulos, Konstantinos Imprialos

  27. Editorial: Arterial Stiffness, Central Haemodynamics and Non-Alcoholic Fatty Liver Disease: Links with Cardiovascular Risk and Effects of Drug Treatment

    Article • Current Vascular Pharmacology, December 2017, Bentham Science Publishers

    Konstantinos Imprialos

  28. Abnormal blood pressure dipping in diabetic kidney disease: A black-race nightmare?

    Article • Journal of Clinical Hypertension, September 2017, Wiley

    Konstantinos Stavropoulos, Konstantinos Imprialos

  29. Testosterone Replacement Therapy and Cardiovascular Risk—A Closer Look at Additional Parameters

    Article • JAMA Internal Medicine, September 2017, American Medical Association (AMA)

    Konstantinos Imprialos

  30. The effect of SGLT2 inhibitors on cardiovascular events and renal function

    Article • Expert Review of Clinical Pharmacology, August 2017, Taylor & Francis

    Konstantinos Imprialos

  31. Bypass of confirmatory tests for case detection of primary aldosteronism in leaner patients?

    Article • Journal of Clinical Hypertension, July 2017, Wiley

    Konstantinos Stavropoulos, Konstantinos Imprialos

  32. Hematocrit and Stroke: A Forgotten and Neglected Link?

    Article • Seminars in Thrombosis and Hemostasis, June 2017, Thieme Publishing Group

    Konstantinos Imprialos

  33. SGLT-2 Inhibitors and Cardiovascular Risk in Diabetes Mellitus: A Comprehensive and Critical Review of the Literature

    Article • Current Pharmaceutical Design, May 2017, Bentham Science Publishers

    Konstantinos Imprialos

  34. Novel Drugs for Hypertension and Heart Failure: Struggling for a Place Under the Sun

    Article • Current Pharmaceutical Design, May 2017, Bentham Science Publishers

    Konstantinos Imprialos

  35. Obstructive sleep apnea, hypertension, and fibrin clot properties

    Article • Journal of Hypertension, May 2017, Wolters Kluwer Health

    Konstantinos Imprialos

  36. Blood pressure and cardiovascular outcomes: a closer look

    Article • The Lancet, April 2017, Elsevier

    Konstantinos Imprialos

  37. Stroke paradox with SGLT-2 inhibitors: a play of chance or a viscosity-mediated reality?

    Article • Journal of Neurology Neurosurgery & Psychiatry, November 2016, BMJ

    Konstantinos Imprialos

  38. Editorial: The microRNA 221/222 Cluster: Inaugurating a New Era in Cardiovascular Disease and Cancer?

    Article • Current Vascular Pharmacology, November 2016, Bentham Science Publishers

    Konstantinos Imprialos

  39. Echocardiographic Parameters During Long and Short Interdialytic Intervals in Hemodialysis Patients

    Article • American Journal of Kidney Diseases, November 2016, Elsevier

    Konstantinos Imprialos

  40. [PP.09.09] EFFECT OF HEMODIALYSIS ON NOVEL ECHOCARDIOGRAPHIC AND TISSUE DOPPLER-DERIVED INDICES OF LEFT VENTRICULAR FUNCTION IN END-STAGE RENAL DISEASE PATIENTS

    Article • Journal of Hypertension, September 2016, Wolters Kluwer Health

    Konstantinos Imprialos

  41. [PP.09.05] HEMODIALYSIS IMPROVES RIGHT VENTRICULAR SIZING AND REDUCES PULMONARY CIRCULATION LOADING IN PATIENTS WITH END-STAGE RENAL DISEASE

    Article • Journal of Hypertension, September 2016, Wolters Kluwer Health

    Konstantinos Imprialos

  42. [PP.10.23] EVALUATION OF SODIUM INTAKE IN PATIENTS WITH RESISTANT HYPERTENSION

    Article • Journal of Hypertension, September 2016, Wolters Kluwer Health

    Konstantinos Imprialos

  43. [PP.23.20] PREVALENCE AND SEVERITY OF ERECTILE DYSFUNCTION IN PATIENTS WITH RESISTANT HYPERTENSION

    Article • Journal of Hypertension, September 2016, Wolters Kluwer Health

    Konstantinos Imprialos

  44. [PP.10.15] PREVALENCE OF SEXUAL DYSFUNCTION IN FEMALES WITH RESISTANT HYPERTENSION

    Article • Journal of Hypertension, September 2016, Wolters Kluwer Health

    Konstantinos Imprialos

  45. [PP.23.12] OUT-OF-OFFICE BLOOD PRESSURE MEASUREMENT IN PATIENTS WITH RESISTANT HYPERTENSION IN EVERYDAY CLINICAL PRACTICE

    Article • Journal of Hypertension, September 2016, Wolters Kluwer Health

    Konstantinos Imprialos

  46. Current challenges in antihypertensive treatment in the elderly

    Article • Polish Archives of Internal Medicine, August 2016, Towarzystwo Internistow Polskich/Polish Society of Internal Medicine

    Konstantinos Imprialos

  47. Letter by Imprialos et al Regarding Article, “Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation”

    Article • Circulation, July 2016, Wolters Kluwer Health

    Konstantinos Imprialos

  48. Depression in hypertensive patients

    Article • Journal of Hypertension, July 2016, Wolters Kluwer Health

    Konstantinos Imprialos

  49. SP489EXCESS RIGHT ATRIAL CONGESTION AND PULMONARY CIRCULATION LOADING OVER THE LONG INTERDIALYTIC IN PATIENTS RECEIVING THRICE-WEEKLY HEMODIALYSIS

    Article • Nephrology Dialysis Transplantation, May 2016, Oxford University Press (OUP)

    Konstantinos Imprialos

  50. MP540CHANGES IN LEFT VENTRICULAR SIZING AND FUNCTION OVER THE 3-DAY AND 2-DAY INTERDIALYTIC INTERVALS IN HEMODIALYSIS PATIENTS

    Article • Nephrology Dialysis Transplantation, May 2016, Oxford University Press (OUP)

    Konstantinos Imprialos

  51. Canagliflozin and Hypertension: Is It the Optimal Choice for All Hypertensive Patients?

    Article • Journal of Clinical Hypertension, April 2016, Wiley

    Konstantinos Imprialos

  52. PATHWAY-2: spironolactone for resistant hypertension

    Article • The Lancet, April 2016, Elsevier

    Konstantinos Imprialos

  53. Poor adoption of guideline recommendations about out-of-office blood pressure measurement in patients with resistant hypertension

    Article • Journal of the American Society of Hypertension, April 2016, Elsevier

    Konstantinos Imprialos

  54. Antihypertensive Drug-Related Side Effects: Is It the Unique Indicator for Nonadherence?

    Article • American Journal of Hypertension, March 2016, Oxford University Press (OUP)

    Konstantinos Imprialos

  55. Renin-Angiotensin System Inhibitors: Do They Have the Same Impact at All Ages?

    Article • Journal of Clinical Hypertension, March 2016, Wiley

    Konstantinos Imprialos

  56. Discontinuation of Antihypertensive Treatment in Elderly Patients and Cognitive Function

    Article • JAMA Internal Medicine, March 2016, American Medical Association (AMA)

    Konstantinos Imprialos

  57. The Role of Mean Platelet Volume in Chronic Obstructive Pulmonary Disease Exacerbation

    Article • Respiratory Care, November 2015, Daedalus Enterprises

    Konstantinos Imprialos

  58. Sodium–glucose cotransporter-2 inhibitors and blood pressure decrease

    Article • Journal of Hypertension, November 2015, Wolters Kluwer Health

    Konstantinos Imprialos

  59. PP.17.12

    Article • Journal of Hypertension, June 2015, Wolters Kluwer Health

    Konstantinos Imprialos

  60. PP.17.13

    Article • Journal of Hypertension, June 2015, Wolters Kluwer Health

    Konstantinos Imprialos

  61. A study on ambulatory measurement of central hemodynamics on healthy individuals with no cardiovascular risk factors

    Article • Artery Research, December 2014, Elsevier

    Konstantinos Imprialos

  62. The Association Between Dyslipidemia and Its Treatment with Erectile Dysfunction

    Article • October 2014, Springer Science + Business Media

    Konstantinos Imprialos

  63. Nanotechnology in cancer treatment

    Article • September 2011, SPIE

    Konstantinos Imprialos